Safety, tolerability, and immunogenicity of the novel antituberculous vaccine RUTI: randomized, placebo-controlled phase II clinical trial in patients with latent tuberculosis infe...

by Andre S Nell, Eva D'lom, Patrick Bouic, Montserrat Sabaté, Ramon Bosser, Jordi Picas, Mercè Amat, Gavin Churchyard, Pere-Joan Cardona
Published 2014-01-01

Predicting the artificial immunity induced by RUTI® vaccine against tuberculosis using universal immune system simulator (UISS)

by Marzio Pennisi, Giulia Russo, Giuseppe Sgroi, Angela Bonaccorso, Giuseppe Alessandro Parasiliti Palumbo, Epifanio Fichera, Dipendra Kumar Mitra, Kenneth B. Walker, Pere-Joan Cardona, Merce Amat, Marco Viceconti, Francesco Pappalardo
Published 2019-12-01

RUTI Vaccination Enhances Inhibition of Mycobacterial Growth ex vivo and Induces a Shift of Monocyte Phenotype in Mice

by Satria A. Prabowo, Satria A. Prabowo, Hannah Painter, Hannah Painter, Andrea Zelmer, Andrea Zelmer, Steven G. Smith, Steven G. Smith, Karin Seifert, Merce Amat, Pere-Joan Cardona, Pere-Joan Cardona, Helen A. Fletcher, Helen A. Fletcher
Published 2019-04-01